Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Breast Cancer Res Treat. 2022 Apr;192(2):435-445. doi: 10.1007/s10549-022-06511-9. Epub 2022 Jan 10.
To describe breast cancer treatment patterns among premenopausal women by age and time since last pregnancy.
Data were analyzed from 1179 women diagnosed with premenopausal breast cancer in the Carolina Breast Cancer Study. Of these, 160 had a recent pregnancy (within 5 years of cancer diagnosis). Relative frequency differences (RFDs) and 95% confidence intervals (CIs) were used to compare cancer stage, treatment modality received, treatment initiation delay (> 30 days), and prolonged treatment duration (> 2 to > 8 months depending on the treatment received) by age and recency of pregnancy.
Recently postpartum women were significantly more likely to have stage III disease [RFD (95% CI) 12.2% (3.6%, 20.8%)] and to receive more aggressive treatment compared to nulliparous women. After adjustment for age, race and standard clinical tumor characteristics, recently postpartum women were significantly less likely to have delayed treatment initiation [RFD (95% CI) - 11.2% (- 21.4%, - 1.0%)] and prolonged treatment duration [RFD (95% CI) - 17.5% (- 28.0%, - 7.1%)] and were more likely to have mastectomy [RFD (95% CI) 14.9% (4.8%, 25.0%)] compared to nulliparous. Similarly, younger women (< 40 years of age) were significantly less likely to experience prolonged treatment duration [RFD (95% CI) - 5.6% (- 11.1%, - 0.0%)] and more likely to undergo mastectomy [RFD (95% CI) 10.6% (5.2%, 16.0%)] compared to the study population as a whole.
These results suggest that recently postpartum and younger women often received prompt and aggressive breast cancer treatment. Higher mortality and recurrence among recently pregnant women are unlikely to be related to undertreatment.
按年龄和距上次妊娠时间描述绝经前妇女的乳腺癌治疗模式。
对 Carolina Breast Cancer Study 中诊断为绝经前乳腺癌的 1179 名女性进行数据分析。其中 160 名最近有妊娠(癌症诊断后 5 年内)。采用相对频率差异(RFD)和 95%置信区间(CI)比较不同年龄和妊娠近期度下的癌症分期、治疗方式、治疗起始延迟(>30 天)和治疗时间延长(根据接受的治疗而延长 2-8 个月)。
产后近期妇女与未生育妇女相比,更有可能患有 III 期疾病(RFD(95%CI)为 12.2%(3.6%,20.8%)),且接受更积极的治疗。调整年龄、种族和标准临床肿瘤特征后,产后近期妇女的治疗起始延迟明显减少(RFD(95%CI)为-11.2%(-21.4%,-1.0%)),治疗时间延长明显减少(RFD(95%CI)为-17.5%(-28.0%,-7.1%)),且更有可能接受乳房切除术(RFD(95%CI)为 14.9%(4.8%,25.0%))与未生育妇女相比。同样,年轻女性(<40 岁)的治疗时间延长明显减少(RFD(95%CI)为-5.6%(-11.1%,-0.0%)),且更有可能接受乳房切除术(RFD(95%CI)为 10.6%(5.2%,16.0%))与整个研究人群相比。
这些结果表明,产后近期和年轻女性通常接受及时和积极的乳腺癌治疗。最近妊娠妇女的死亡率和复发率较高,不太可能与治疗不足有关。